MindWalk Holdings HYFT
NASDAQ HYFT
$1.33 +0.00 (+0.00%)
As of: Sep 4, 2026 · 2:23 PM EDT

MindWalk Holdings (HYFT) Other Working Capital Changes (2023 - 2026)

MindWalk Holdings (HYFT) posted quarterly Other Working Capital Changes of $44675.3 for Q1 2026, down 90.11% year-over-year from $451537.6 in Q1 2025, and down 49.62% quarter-over-quarter from $88668.1 in Q4 2025.

Analysis

MindWalk Holdings (HYFT) Other Working Capital Changes (2023 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Other Working Capital Changes for 4 consecutive years, with $44675.3 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 90.11% year-over-year to $44675.3; the TTM figure through Jan 2026 stood at $806855.6 (down 20.9% YoY), while the FY2021 annual figure was -$214089.0, changed N/A from the prior year.
  • Other Working Capital Changes fell to $44675.3 in Q1 2026 per HYFT's latest filing, from $88668.1 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $428291.5 in Q1 2025 and bottomed at -$630185.3 in Q1 2023.
  • Historically, Other Working Capital Changes has averaged $1877.8 across 4 years, with a median of $39303.8 in 2024.
  • Annual changes were most pronounced in 2024 — Other Working Capital Changes tumbled 137.1% — and 2025, when it jumped 615.16%.
  • MindWalk Holdings' Other Working Capital Changes stood at $350309.6 in 2023, then decreased by 14.08% to $300970.7 in 2024, then slumped by 70.54% to $88668.1 in 2025, then sank by 49.62% to $44675.3 in 2026.
  • Business Quant data shows HYFT's Other Working Capital Changes at $44675.3 in Q1 2026, $88668.1 in Q4 2025, and $221974.5 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 MindWalk Holdings 61.69 Mn 53.41 Mn 1.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 119,638.99
Apr 30, 2026 119,638.99
Jan 31, 2026 44,675.32
Jan 31, 2026 44,675.32
Oct 31, 2025 88,668.12
Oct 31, 2025 88,668.12
Jul 31, 2025 221,974.53
Jul 31, 2025 221,974.53
Apr 30, 2025 -910,033.65
Apr 30, 2025 -910,033.65
Jan 31, 2025 451,537.61
Jan 31, 2025 451,537.61
Oct 31, 2024 300,970.66
Oct 31, 2024 300,970.66
Jul 31, 2024 -43,088.41
Jul 31, 2024 -43,088.41
Apr 30, 2024 -498,563.71
Apr 30, 2024 -498,563.71
Jan 31, 2024 310,683.02
Jan 31, 2024 310,683.02